Heterogeneity of tumor immune microenvironment of EGFR/ALK-positive tumors versus EGFR/ALK-negative tumors in resected brain metastases from lung adenocarcinoma.
Xiao G, Li L, Tanzhu G, Liu Z, Gao X, Wan X, Xiao D, Chen L, Xia X, Zhou R.
J Immunother Cancer. 2023 Mar;11(3):e006243. doi: 10.1136/jitc-2022-006243.
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers.
Trebeschi S, Drago SG, Birkbak NJ, Kurilova I, Cǎlin AM, Delli Pizzi A, Lalezari F, Lambregts DMJ, Rohaan MW, Parmar C, Rozeman EA, Hartemink KJ, Swanton C, Haanen JBAG, Blank CU, Smit EF, Beets-Tan RGH, Aerts HJWL.
Ann Oncol. 2019 Jun 1;30(6):998-1004. doi: 10.1093/annonc/mdz108.
Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms.
Ferencz B, Török K, Pipek O, Fillinger J, Csende K, Lantos A, Černeková R, Mitták M, Škarda J, Delongová P, Megyesfalvi E, Schelch K, Lang C, Solta A, Boettiger K, Brcic L, Lindenmann J, Rényi-Vámos F, Aigner C, Berta J, Megyesfalvi Z, Döme B.
Cancer Immunol Immunother. 2024 May 2;73(6):114. doi: 10.1007/s00262-024-03704-7.
Adjuvant Therapy of Resected Non-small Cell Lung Cancer: can We Move Forward?
Buffoni L, Vavalà T, Novello S.
Curr Treat Options Oncol. 2016 Oct;17(10):54. doi: 10.1007/s11864-016-0429-x.
Parity and risk of lung cancer in women: systematic review and meta-analysis of epidemiological studies.
Dahabreh IJ, Trikalinos TA, Paulus JK.
Lung Cancer. 2012 May;76(2):150-8. doi: 10.1016/j.lungcan.2011.10.014. Epub 2011 Dec 9.
Solitary Fibrous Tumors of the Lung: A Clinicopathological Analysis of 52 Cases.
Wang YX, Zhong Y, Fan SS, Zhu YS, Peng XR, Zhang X.
Curr Oncol. 2023 Feb 1;30(2):1784-1793. doi: 10.3390/curroncol30020138.
Inflammatory myofibroblastic tumor of the lung in children: anaplastic lymphoma kinase (ALK) expression and clinico-pathological correlation.
Siminovich M, Galluzzo L, López J, Lubieniecki F, de Dávila MT.
Pediatr Dev Pathol. 2012 May-Jun;15(3):179-86. doi: 10.2350/11-10-1105-OA.1. Epub 2012 Jan 26.
Prognostic impact of underlying lung disease in pulmonary wedge resection for lung cancer.
Kawaguchi T, Sawabata N, Miura S, Kawai N, Yasukawa M, Tojo T, Taniguchi S.
Int J Clin Oncol. 2019 Apr;24(4):366-374. doi: 10.1007/s10147-018-1367-3. Epub 2018 Nov 15.
Controversies in the management of stage III non-small-cell lung cancer.
Biswas T, Sharma N, Machtay M.
Expert Rev Anticancer Ther. 2014 Mar;14(3):333-47. doi: 10.1586/14737140.2014.867809. Epub 2014 Jan 8.
Pre-operative pulmonary evaluation of lung cancer patients: a review of the literature.
van Tilburg PM, Stam H, Hoogsteden HC, van Klaveren RJ.
Eur Respir J. 2009 May;33(5):1206-15. doi: 10.1183/09031936.00020508.
